We provide you with 20 years of free, institutional-grade data for TAK stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of TAK. Explore the full financial landscape of TAK stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| TAKEDA PHARMACEUTICAL CO LTD | Sale | -3,703,703 | $8.1 | $29,999,994 | 2024-01-25 |
The information provided in this report about TAK stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Takeda Pharmaceutical Company Limited(NYSE:TAK) 
Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. It offers pharmaceutical products in the areas of gastroenterology; oncolog...
Website: http://www.takeda.com
Founded: 1781
Full Time Employees: 47,495
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic